HomeOpen Access NewsNeurodegenerative Diseases

Neurodegenerative Diseases

Breakthrough molecule discovery offers hope for new motor neurone disease treatments

Scientists have discovered a molecule that could aid the development of new treatments for motor neurone disease, a new study suggests.

Mouth and gut bacteria linked to brain changes in Parkinson’s disease

Scientists have found a link between bacteria in the mouth and gut and the progression of cognitive decline in Parkinson's disease.

Addressing the challenges of MS: Progress, policy, and pathways forward

MS Australia is a national not-for-profit organisation dedicated to improving the lives of those affected by multiple sclerosis. Its remit includes supporting research for...

Chronic sleep problems linked to higher dementia risk in older adults

People who experience sleep disorders are at greater risk of developing dementia and other neurodegenerative conditions later in life.

Experimental drug ‘Ulefnersen’ offers unprecedented hope for rare form of ALS

An experimental drug known as ulefnersen has shown remarkable efficacy in treating a rare, aggressive form of ALS. Some patients experienced unprecedented functional recovery, offering new hope in a previously devastating diagnosis.

Low-dose interleukin-2 found safe and effective for slowing motor neurone disease progression

A major clinical trial has found that low-dose interleukin-2 (IL2LD) is safe and may significantly extend survival in people with motor neurone disease (ALS).

Researchers identify the key metabolic drivers of Parkinson’s disease

Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for treatment.

Study reveals brain trauma’s role in Alzheimer’s disease development

For nearly a century, medical experts have known that individuals who suffer brain trauma, such as traumatic brain injury (TBI), are at an increased risk of developing dementia later in life.

Breakthrough in diagnosing dementia with Lewy bodies through voice analysis

Researchers have found a new method to distinguish between Dementia with Lewy Bodies (DLB) and Alzheimer's Disease (AD) using vocal emotional expressions.

The truth behind ApoE4 gene variant and your risk of developing Alzheimer’s Disease

Researchers have found evidence suggesting that lifestyle factors may play a pivotal role in mitigating the risk of Alzheimer's disease, even among individuals carrying the ApoE4 gene variant.

Five rare diseases you never knew existed

Learn about these five rare diseases to support governments, scientists and healthcare professionals to find treatments.

Multiple sclerosis – the disease of a thousand faces

Multiple sclerosis (MS) is a disease that impacts the central nervous system, affecting everything we do. For many patients, the main question is: how do I confront this life-changing condition?

An introduction to spina bifida and its available treatments

Dr Nauf AlBendar, Doctor of Clinical Medicine & Founder of The Womb Effect, introduces spina bifida, the primary cause of foetal loss and substantial disabilities in newborns.

The secret genetic risk of schizophrenia uncovered

The secret of the genetic risk of schizophrenia has been hiding in plain sight — the placenta, says the groundbreaking study conducted by the Lieber Institute for Brain Development.

Neuromyelitis optica (NMO) – on the path to a cure

Dr. Ludivine Herman, Project Leader at immunotherapy specialist Imcyse, walks us through Neuoromyelitis optica facts & trends, the challenges of current therapies and the potential of immunotherapies.

Treatments for Alzheimer’s disease: understanding causes, diagnosis, prevention & cure

Abbas Kanani, Superintendent Pharmacist at Chemist Click Online Pharmacy, walks us through treatments for Alzheimer’s disease, researching the causes, diagnosis, prevention, and cure.

What is the optimal window for the early detection of Alzheimer’s disease?

Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for the detection of Alzheimer’s disease and how soon in the disease’s trajectory detection can make a meaningful difference in a patient’s prognosis.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders